Jenny Scherzer

Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries

Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer et al. · Sexually Transmitted Infections · 2021 · 48 citations · Full text

Pharmacy, Health Sciences, Pharmacotherapy +17

Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe

Babatunde Akinwunmi, Daniel Buchenberger, Jenny Scherzer et al. · European Journal of Public Health · 2020 · 30 citations · Full text

Public Health, Pharmacotherapy, Hiv Control +15

Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study

Cristina Mussini, Charles Cazanave, Eisuke Adachi et al. · AIDS and Behavior · 2024 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

Hamzah Z. Farooq, Vanessa Apea, Bakita Kasadha et al. · BMJ Open · 2023 · 15 citations · Full text

Public Health, Health Policy, Pharmacotherapy +17

Implementation of long‐acting cabotegravir and rilpivirine: primary results from the perspective of staff study participants in the Cabotegravir And Rilpivirine Implementation Study in European Locations

Cassidy A. Gutner, Laurent Hocqueloux, Celia Jonsson‐Oldenbüttel et al. · Journal of the International AIDS Society · 2024 · 11 citations · Full text

Public Health, Infectious Disease Control, Pharmacotherapy +17